Company ToolGen Incorporated

Equities

A199800

KR7199800004

Biotechnology & Medical Research

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Holdings

Company contact information

Sector

Sales per Business

Sales per region

Sector Other Biotechnology & Medical Research

End-of-day quote Korea S.E. Other stock markets 18:00:00 2024-05-09 EDT			5-day change	1st Jan Change
64,400 ^KRW	+0.78%		-3.01%	-8.26%

2023	ToolGen Incorporated announced that it has received KRW 33 billion in funding	CI
2023	ToolGen Incorporated announced that it expects to receive KRW 33 billion in funding	CI

ToolGen, Inc. is principally engaged in the development of engineered nucleases. The Companyâs main products portfolio consists of ribose nucleic acid (RNA)-guided endonucleases (RGEN) as well as deoxyribonucleic acid (DNA)-directed RGEN (dRGEN), which are applied as tools for editing genetic information in microbial, plant, animal and human cells. In addition, it is involved in the provision of genome engineering services.

KRW in Million	2022	Weight	2023	Weight	Delta
Other 92.2 %	495	66.6 %	1,018	92.2 %	+105.48%
Genetic Correction Related Technology Goods 3.9 %	80	10.8 %	43	3.9 %	-45.60%
Analysis Services 3.8 %	168	22.6 %	42	3.8 %	-74.83%

KRW in Million	2022	Weight	2023	Weight	Delta
North America 59.3 %	394	53.0 %	655	59.3 %	+66.06%
South Korea 15.9 %	290	39.0 %	176	15.9 %	-39.37%
Europe 14.0 %	59	8.0 %	154	14.0 %	+159.80%
Asia 10.8 %	-	-	119	10.8 %	-

Managers	Title	Age	Since
Young-Ho Kim CEO	Chief Executive Officer	59	-
Byung-Hwa Lee CEO	Chief Executive Officer	56	19-09-03
Seok-Joong Kim CTO	Chief Tech/Sci/R&D Officer	48	-
Jun-Seong Jo PRN	Corporate Officer/Principal	46	-
Yu-Ri Kim LAW	General Counsel	57	-
Gyung-Seong Min AUD	Comptroller/Controller/Auditor	56	-

Members of the board	Title	Age	Since
Chang-Kyu Kim BRD	Director/Board Member	57	-
Il-Ho Ha BRD	Director/Board Member	65	-
Byung-Hwa Lee CEO	Chief Executive Officer	56	19-09-03
Seong-Joon Hong BRD	Director/Board Member	59	21-02-28
Seok-Joong Kim BRD	Director/Board Member	48	-
Young-Ho Kim CEO	Chief Executive Officer	59	-

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	7,930,258	6,094,036 ( 76.85 %)	2,500 ( 0.0315 %)	76.85 %

Name	Equities	%	Valuation
GENEXINE, INC. 14.10 %	1,118,347	14.10 %	56 M ₩
Jin-Soo Kim 8.577 %	680,144	8.577 %	34 M ₩
Sae-hee Han 3.793 %	300,800	3.793 %	15 M ₩
ToolGen, Inc. ESOA 0.4443 %	35,231	0.4443 %	2 M ₩
So-ra Kim 0.1324 %	10,500	0.1324 %	529 582 ₩
Soon-il Gwon 0.0514 %	4,075	0.0514 %	205 528 ₩
Ji-hak Han 0.0330 %	2,615	0.0330 %	131 891 ₩
TOOLGEN INCORPORATED 0.0315 %	2,500	0.0315 %	126 091 ₩
Byung-Hwa Lee 0.0252 %	2,000	0.0252 %	100 873 ₩
Seong-Joon Hong 0.000000 %	0	0.000000 %	- ₩

Name	Equities	%	Valuation
TOOLGEN INCORPORATED 0.03%	2,500	0.03%	126,091 $

ToolGen, Inc.

1204 Byucksan Digital Valley 6-cha 219 Gasan Digital 1-ro

08501, Seoul

http://www.toolgen.com

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Other Biotechnology & Medical Research

	1st Jan change	Capi.
TOOLGEN INCORPORATED	-8.26%	373M
MODERNA, INC.	+17.96%	44.96B
IQVIA HOLDINGS INC.	+1.17%	42.65B
LONZA GROUP AG	+48.77%	41.85B
CELLTRION, INC.	-4.27%	29.04B
ICON PUBLIC LIMITED COMPANY	+11.42%	26.08B
ALNYLAM PHARMACEUTICALS, INC.	-21.39%	19.03B
BIO-TECHNE CORPORATION	+4.86%	12.75B
MEDPACE HOLDINGS, INC.	+27.29%	12.06B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-3.50%	11.75B

Other Biotechnology & Medical Research